View Older Stories View More Recent Stories

Jun 17, 2024 04:00PM Quanterix to Participate at the Scotiabank Healthcare 1x1 Day
Jun 5, 2024 04:00PM Quanterix to Present at 45th Annual Goldman Sachs Global Healthcare Conference
May 22, 2024 04:00PM Quanterix to Present at Leerink Partners Healthcare Crossroads Conference 2024
May 7, 2024 04:00PM Quanterix Releases Financial Results for the First Quarter of 2024
Apr 29, 2024 04:00PM Quanterix To Report First Quarter 2024 Financial Results
Mar 21, 2024 05:30PM Quanterix Outlines Partner Path With Labs to Expedite Building Global Alzheimer’s Disease Testing Infrastructure
Mar 4, 2024 09:01AM Quanterix (QTRX) Granted FDA Breakthrough Device Designation for p-Tau 217 Test
Mar 4, 2024 09:00AM Quanterix Granted Breakthrough Device Designation from U.S. FDA for Blood-Based p-Tau 217 Test for Alzheimer’s Disease
Feb 29, 2024 04:00PM Quanterix Releases Operating Results for Fourth Quarter and Full Year 2023
Feb 26, 2024 06:59PM Quanterix (QTRX) Reaffirms 2023 Guidance
Feb 26, 2024 06:58PM Quanterix Reschedules Q4 and Full Year 2023 Earnings Conference Call; Reaffirms 2023 Guidance
Feb 26, 2024 09:00AM Quanterix Announces First Collaborations with Five Health Networks to Aid the Diagnosis and Clinical Management of Individuals with Alzheimer’s Disease
Feb 23, 2024 04:30PM Quanterix to Present at Cowen’s 44th Annual Health Care Conference
Feb 16, 2024 04:00PM Quanterix Fourth Quarter Earnings and Full Year 2023 Financial Results Conference Call
Dec 12, 2023 04:00PM Quanterix to Present at 42nd Annual J.P. Morgan Healthcare Conference
Nov 13, 2023 04:00PM Quanterix To Participate at The Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum
Nov 6, 2023 04:50PM Quanterix Releases Operating Results for Third Quarter 202
Oct 30, 2023 04:00PM Quanterix to Report Third Quarter 2023 Financial Results on November 7, 2023
Oct 24, 2023 04:30PM Quanterix Launches High Accuracy p-Tau 217 Blood Biomarker Test to Aid Physician Diagnosis of Alzheimer’s Disease
Oct 24, 2023 05:51AM Quanterix (QTRX) Enters New Agreement to Advance Blood Based Alzheimer's Disease Detection
Oct 23, 2023 08:30PM Quanterix Announces New Agreement to Advance Blood Based Alzheimer's Disease Detection
Sep 28, 2023 05:00PM Quanterix CEO to Speak at Goldman Sachs Alzheimer’s Disease Day
Sep 5, 2023 08:00AM Quanterix to Participate at the Morgan Stanley 21st Annual Global Healthcare Conference
Aug 21, 2023 04:30PM Quanterix (QTRX) Appoints William P. Donnelly to its Board
Aug 21, 2023 04:30PM William P. Donnelly Appointed to Quanterix’s Board of Directors
Aug 9, 2023 08:30AM Quanterix (QTRX) Appoints Vandana Sriram as CFO
Aug 9, 2023 08:30AM Quanterix Appoints Vandana Sriram as Chief Financial Officer
Aug 7, 2023 05:13PM Quanterix Releases Operating Results for Second Quarter 2023
Aug 3, 2023 08:00AM Quanterix to Present at Canaccord Genuity 43rd Annual Growth Conference
Jul 31, 2023 08:00AM Quanterix’s Simoa® Technology Powers Large, International Reference Range Study Utilizing Serum Neurofilament Light (sNfL) to Assess Neurological Disease Activity in Pediatric Patients
Jul 20, 2023 08:00AM Quanterix to Report Second Quarter 2023 Financial Results on August 8, 2023
Jul 6, 2023 05:37PM Quanterix Launches LucentAD Biomarker Blood Test to Aid Physician Diagnosis of Alzheimer’s Disease in Patients
Jun 7, 2023 04:00PM Quanterix to Participate in Fireside Chat at Goldman Sachs Annual Global Healthcare Conference
May 9, 2023 04:00PM Quanterix Releases Operating Results for First Quarter 2023
May 2, 2023 04:30PM Quanterix’s First Quarter 2023 Earnings Conference Call
Apr 25, 2023 04:33PM Quanterix (QTRX) Announces FDA Accelerated Approval of Tofersen Highlights Importance of Blood Neurofilament Light Chain as Surrogate Endpoint in Neurology Therapeutic Trials
Apr 25, 2023 04:30PM FDA Accelerated Approval of Tofersen Highlights Importance of Blood Neurofilament Light Chain as Surrogate Endpoint in Neurology Therapeutic Trials
Mar 8, 2023 04:30PM Quanterix to Participate in Barclays Global Healthcare Conference
Mar 6, 2023 08:09AM Quanterix Releases Operating Results for Fourth Quarter and Full Year 2022; Aligned with Expectations
Feb 28, 2023 04:30PM Quanterix to Present at Cowen’s 43rd Annual Health Care Conference
Feb 24, 2023 04:30PM Quanterix Fourth Quarter Earnings and Full Year 2022 Financial Results Conference Call
Feb 24, 2023 04:30PM Quanterix Fourth Quarter Earnings and Full Year 2022 Financial Results Conference Call
Jan 9, 2023 04:31PM Quanterix (QTRX) Announces Appointment of Brian Blaser to Board of Directors
Jan 9, 2023 04:30PM Quanterix Announces Appointment of Brian Blaser to Board of Directors
Jan 9, 2023 08:30AM Quanterix Expands Laboratory Developed Test Menu with Launch of Neurofilament Light Chain Test
Jan 3, 2023 04:00PM Quanterix to Present at 41st Annual J.P. Morgan Healthcare Conference
Dec 5, 2022 04:36PM Quanterix’s Simoa® Technology Drives Advances in Alzheimer’s Disease Research Presented at 2022 Clinical Trials on Alzheimer’s Disease (CTAD) Conference
Nov 16, 2022 04:30PM Quanterix to Participate in the 15th Clinical Trials on Alzheimer’s Disease (CTAD) Task Force
Nov 10, 2022 04:30PM Quanterix to Participate in the Canaccord MedTech, Diagnostics and Digital Health & Services Forum
Nov 8, 2022 04:00PM Quanterix Corporation Releases Operating Results for Third Quarter 2022
View More Recent Stories View Older Stories